PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3, 4, 5,-trisphosphate and Akt/protein kinase B signaling pathway
H Sun, R Lesche, DM Li, J Liliental… - Proceedings of the …, 1999 - National Acad Sciences
To investigate the molecular basis of PTEN-mediated tumor suppression, we introduced a
null mutation into the mouse Pten gene by homologous recombination in embryonic stem (ES) …
null mutation into the mouse Pten gene by homologous recombination in embryonic stem (ES) …
Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo
M Groszer, R Erickson, DD Scripture-Adams, R Lesche… - Science, 2001 - science.org
The mechanisms controlling neural stem cell proliferation are poorly understood. Here we
demonstrate that the PTEN tumor suppressor plays an important role in regulating neural stem/…
demonstrate that the PTEN tumor suppressor plays an important role in regulating neural stem/…
[PDF][PDF] PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and-independent mechanisms
DJ Freeman, AG Li, G Wei, HH Li, N Kertesz, R Lesche… - Cancer cell, 2003 - cell.com
We show in this study that PTEN regulates p53 protein levels and transcriptional activity
through both phosphatase-dependent and -independent mechanisms. The onset of tumor …
through both phosphatase-dependent and -independent mechanisms. The onset of tumor …
DNA methylation biomarkers for blood-based colorectal cancer screening
…, J Distler, M Schuster, X Song, R Lesche… - Clinical …, 2008 - academic.oup.com
Background: Sensitive, specific blood-based tests are difficult to develop unless steps are
taken to maximize performance characteristics at every stage of marker discovery and …
taken to maximize performance characteristics at every stage of marker discovery and …
Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity
…, R Sherwin, S Devaskar, R Lesche… - Proceedings of the …, 2004 - National Acad Sciences
In the liver, insulin controls both lipid and glucose metabolism through its cell surface
receptor and intracellular mediators such as phosphatidylinositol 3-kinase and serine-threonine …
receptor and intracellular mediators such as phosphatidylinositol 3-kinase and serine-threonine …
[PDF][PDF] Cre/loxP-mediated inactivation of the murinePten tumor suppressor gene
R Lesche, M Groszer, J Gao, Y Wang, A Messing… - genesis, 2002 - academia.edu
PTEN (or MMAC1/TEP1) tumor suppressor gene is frequently mutated in a variety of human
cancers and in three cancer predisposition syndromes (Eng and Peacocke, 1998; Dahia, …
cancers and in three cancer predisposition syndromes (Eng and Peacocke, 1998; Dahia, …
[HTML][HTML] Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases
J Liliental, SY Moon, R Lesche, R Mamillapalli, D Li… - Current Biology, 2000 - cell.com
Pten (Phosphatase and tensin homolog deleted on chromosome 10) is a recently identified
tumor suppressor gene which is deleted or mutated in a variety of primary human cancers …
tumor suppressor gene which is deleted or mutated in a variety of primary human cancers …
Tumour class prediction and discovery by microarray-based DNA methylation analysis
…, G Grabs, A Howe, M Kursar, R Lesche… - Nucleic acids …, 2002 - academic.oup.com
Aberrant DNA methylation of CpG sites is among the earliest and most frequent alterations
in cancer. Several studies suggest that aberrant methylation occurs in a tumour type-specific …
in cancer. Several studies suggest that aberrant methylation occurs in a tumour type-specific …
Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland
G Li, GW Robinson, R Lesche, H Martinez-Diaz… - 2002 - journals.biologists.com
PTEN tumor suppressor is frequently mutated in human cancers, including breast cancers.
Female patients with inherited PTEN mutations suffer from virginal hypertrophy of the breast …
Female patients with inherited PTEN mutations suffer from virginal hypertrophy of the breast …
[HTML][HTML] A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome
…, A Buttgereit, Z Makowska, R Lesche… - Nature …, 2021 - nature.com
There is currently no approved treatment for primary Sjögren’s syndrome, a disease that
primarily affects adult women. The difficulty in developing effective therapies is -in part- because …
primarily affects adult women. The difficulty in developing effective therapies is -in part- because …